The US Food and Drug Administration has resorted to a legal
challenge against India's Ranbaxy Laboratories in an ongoing
investigation into the sale of substandard drugs.
Sangamo Biosciences and Sigma-Aldrich have licensed their zinc
finger nuclease (ZFN) technology to Roche to enable the pharma
giant to develop cell lines and transgenic animals.
Agilent has continued its summer spending spree with the
acquisition of US-based Particle Sizing Systems that will further
bolster the firm's Materials Science Services Unit (MSSU).
Praxair China has won the contract to supply the liquid nitrogen
and cooling system for Jiangsu Defeng Pharmaceutical &
Chemical's manufacturing plant.
Electroporation specialist Inovio Biomedical Corp and vaccine
developer VGX Pharmaceuticals believe that their recently announced
merger will create a firm capable of rapidly moving DNA vaccine
candidates from the laboratory to the...
A new Master Cell Bank (MCB) capable of producing pure cell culture
for the manufacture of the anti-biofilm enzyme DispersinB
represents a significant breakthrough, according to developer Kane
Biotech.
The new guidelines for how monographs will be revised and
elaborated to tackle potentially genotoxic impurities (PGIs) have
been published by the European Pharmacopeia Commission.
GlaxoSmithKline (GSK) has sold four of its off-patent drug products
to a South African drugmaker for £170m ($336m), describing the move
as part of an ongoing effort to simplify its manufacturing
operations.
New Mexico-headquartered drugmaker CytoDyn has begun the good
manufacturing practice (GMP) standard production of the
developmental candidate anti-HIV monoclonal antibody Cytolin
(lymphocyte function-associated antigen-1).
Pharmaceutical manufacturers in Vietnam have gained a reprieve
after the Ministry of Health (MoH) informed them that those without
good manufacturing practice (GMP) certificates can continue
production for now.
A deal to sell Pfizer's active pharmaceutical ingredient manufacturing (API) plant in County Cork, Ireland, has fallen through according to a statement by the US drug giant, placing over 180 production jobs under threat.
MDS Analytical Technologies has followed its acquisition of
Molecular Devices last year by snapping up high content screening
(HCS) experts Blueshift for $15m (€9.45m).
Contract research and production specialist Patheon is to promote
BSP Pharmaceuticals' cytotoxic development and manufacturing
services as part of a marketing agreement that the two firms have
signed.
UK-based Sinclair Pharmaceuticals has entered into a manufacturing
and distribution agreement with Wockhardt, an Indian pharmaceutical
and biotech company.
in-PharmaTechnologist.com's periodic round-up of developments in
the field of pharmaceutical facilities includes news of two
environmental fines, MHRA plant approval and a strike at Teva.
A service provider called Binto is filling a much needed vacuum in the clinical trial industry in terms of patient tracking, eliminating the need for big pharmaceutical firms to resort to methods such as hiring private investigators to track down "lost"...
Agilent Technologies has continued its push into the materials
science market with the acquisition of nanoindentation instrument
manufacturer Nano Instruments.
Vivalis has filed the biologics master file (BMF) with the US Food
and Drug Administration for its EB66 vaccine and therapeutic
protein production technology.
Immtech Pharmaceuticals has become the latest in a string of
western research and development services firms to announce a
partnership with a peer in China in a bid to get a foothold in this
market of vast potential.
Pfizer has enlisted outsourcing services firm NovaMed
Pharmaceuticals to conduct the distribution, sales and marketing of
some of its products in the country.
European technical services and industrial engineering specialist
Imtech says it has received orders worth around €40m ($64m) from
the Belgian operations of firms such as Janssen Pharmaceutica,
GlaxoSmithKline (GSK) and Schering Plough.
Industrial separation specialist Upfront Chromatography believes
that its new range of disposable absorption chromatography units
will help monoclonal antibody (MAb) makers significantly reduce
production costs.
in-PharmaTechnologist's round-up of developments in the field of
drug delivery, this week includes: a developmental micro-needle
approach for ocular medications; AlphaRx' anti-infective Zysolin
nanoparticles; and OptiNose's...
Sigma-Aldrich has introduced a new high-throughput (HT) plasmid DNA
purification kit for transfection applications in pharmaceutical
and biotechnology research.
US researchers have developed a more sensitive method of detecting
whether athletes have taken drugs to artificially boost
testosterone which increases physical performance.
UK drug major GlaxoSmithKline is examining operations at its active
pharmaceutical ingredient (API) manufacturing plant in Montrose,
Scotland, with an eye to potential job cuts.
Outsourcing-Pharma.com presents its latest round-up of news in the
contract development and manufacturing sector, with updates from
Rentschler Biotechnologie, Eden Biodesign, Emcure Pharmaceuticals
and new start-up Appian Labs.
STMicroelectronics (ST) and Debiotech, which are based in Lausanne
and Geneva respectively, have completed the production of an
evaluation prototype of their insulin Nanopump.
Visiongain's third annual conference on Pharmaceutical
Anti-counterfeiting Strategies kicks off next week, covering many
aspects of the problem from technological deterrents, regulatory
developments in the EU and US and the implications...
A recent study conducted by Eli Lilly's research laboratories
division suggests that quantitative ion mobility spectrometry
(qIMS) can offer drugmakers a rapid on-site means of verifying the
cleanliness of manufacturing equipment.
IndiaSoft Technologies, which is headquartered in the city of Pune
in Maharashtra state has won the contract to distribute Performance
Fluid Dynamics' (PFD) DynoChem productivity software to drug
manufacturers in the region.
Slovenian drugmaker Krka has paid just under $1.6m (€1m) for 7.5
per cent stakes in two Chinese drug and chemicals firms, namely
Zhejiang Menovo Pharmaceuticals and Anhui Menovo Pharmaceuticals.
Nventa Biopharmaceuticals hopes that the enhanced durability of its
new Poly IC-Poly arginine (Poly-ICR) adjuvant will help it capture
a significant share of the therapeutic and prophylactic vaccine
markets.